Zota Health Care was originally incorporated on July 12, 2000 vide Certificate of Incorporation issued by the Assistant Registrar of Companies, Gujarat, Dadra and Nagar Haveli. It is a pharmaceutical company, engaged in developing, manufacturing and marketing pharmaceutical products. The company mainly market generic, patented and OTC pharmaceutical products, which it commercializes through the network of its distributor channel for its domestic sales.

The company started operations in 2000 by marketing pharmaceutical products on a local level. Over the years the company has built a steady position for itself in the domestic market. The backbone of the company’s revenue from operations is its distribution network, team of medical representatives and its marketing team. In addition to being vast, the company’s product portfolio is also diversified in nature, with its offerings ranging from allopathic medicine to ayurvedic to healthcare products. It offers varieties of tablets, capsules, ointments, oral liquids, injectable to meet customer needs. The company has also ensured to have its presence spread throughout the country and has achieved the same by supplying in all the 4 regions of the country. The company has applied for patent of 19 unique formulations, wherein it has been granted approvals for 6 formulations.

The company has also taken initiatives for digital marketing strategy and has already launched a mobile application for its division ‘Nutravedic.com’ and is in process of launching another application to integrate the markets and reach customers at large. Further, it has purchased the marketing rights of Astra-Idl for a period of three years to strengthen its market segment of generic medicines.

Business area of the company

Zota Health Care Ltd.

Bajaj Healthcare Ltd.

SMS Pharmaceuticals Ltd.

Jagsonpal Pharmaceuticals Ltd.

Panacea Biotec Ltd.

Solara Active Pharma Sciences Ltd.

NGLFINE

Windlas Biotech Ltd.

Kopran Ltd.

Hester Biosciences Ltd.

Sakar Healthcare Ltd.

Lincoln Pharmaceuticals Ltd.

Medicamen Biotech Ltd.

Nectar Lifesciences Ltd.

Themis Medicare Ltd.

Market Cap	1,067 Cr	ROE	-6.8%
P/E Ratio(TTM)	0.0	EPS(TTM)	0.0
P/B Ratio	11.0	Dividend Yield	0.2%
Industry P/E	40.0	Book Value	37.4
		Face Value	10.0

Fundamentals